Order Article Reprints

Paramakrishnan N, Lim KG, Paramaswaran Y, Ali N, Waseem M, Shazly GA, Bin Jardan YA, Muthuraman A. Astaxanthin: A Marine Drug That Ameliorates Cerebrovascular-Damage-Associated Alzheimer’s Disease in a Zebrafish Model via the Inhibition of Matrix Metalloprotease-13. Marine Drugs. 2023; 21(8):433. https://doi.org/10.3390/md21080433

Paramakrishnan, Nallupillai, Khian Giap Lim, Yamunna Paramaswaran, Nemat Ali, Mohammad Waseem, Gamal A. Shazly, Yousef A. Bin Jardan, and Arunachalam Muthuraman. 2023. "Astaxanthin: A Marine Drug That Ameliorates Cerebrovascular-Damage-Associated Alzheimer’s Disease in a Zebrafish Model via the Inhibition of Matrix Metalloprotease-13" Marine Drugs 21, no. 8: 433. https://doi.org/10.3390/md21080433

Paramakrishnan, N., Lim, K. G., Paramaswaran, Y., Ali, N., Waseem, M., Shazly, G. A., Bin Jardan, Y. A., & Muthuraman, A. (2023). Astaxanthin: A Marine Drug That Ameliorates Cerebrovascular-Damage-Associated Alzheimer’s Disease in a Zebrafish Model via the Inhibition of Matrix Metalloprotease-13. Marine Drugs, 21(8), 433. https://doi.org/10.3390/md21080433